Frank R, Fontaine G, Guiraudon G, Grosgogeat Y
Nouv Presse Med. 1982 Apr 10;11(17):1325-9.
Tachycardias in Wolff-Parkinson-White syndrome are due to the presence of an accessory conduction pathway between atria and ventricles. Many patients are treated with anti-arrhythmic drugs alone or in combinations. In difficult cases, the choice of therapy is guided by investigatory methods using Holter's recording system and intracavitary electrophysiological techniques, sometimes associated with special pacemakers arresting reciprocal rhythm. Intolerance to such pacemakers or failure of medical treatments usually leads to surgery. Division of the accessory conduction pathway constitutes a radical treatment of the syndrome with satisfactory results when performed by trained teams.
预激综合征中的心动过速是由于心房和心室之间存在附加传导通路所致。许多患者仅接受抗心律失常药物治疗或联合用药。在疑难病例中,治疗方案的选择以使用动态心电图记录系统和心腔内电生理技术的检查方法为指导,有时还会联合使用能终止折返心律的特殊起搏器。对这类起搏器不耐受或药物治疗失败通常会导致手术治疗。由训练有素的团队进行附加传导通路切断术是该综合征的一种根治性治疗方法,效果令人满意。